Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126273
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:32
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgx-20240930.htm   iXBRL 10-Q 2737108
2 EX-31.1 mgx-ex31_1.htm EX-31.1 16083
3 EX-31.2 mgx-ex31_2.htm EX-31.2 16026
4 EX-32.1 mgx-ex32_1.htm EX-32.1 13727
  Complete submission text file 0000950170-24-126273.txt   10059955

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20240930.xsd EX-101.SCH 1386833
63 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20240930_htm.xml XML 1707406
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41949 | Film No.: 241453864
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)